World's Best Scientists 2026 revealed!
Journal of Clinical Pharmacology
H-index 19

Journal of Clinical Pharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1407 137 139 17

Additional Metrics

Number of Best Scientists*: 220
Documents by Best Scientists*: 190
Top 100 Ranked Scientists*: 9
SCIMAGO H-index: 133
SCIMAGO SJR: 0.756
Impact Factor: 2.3

Overview

Top Research Topics at The Journal of Clinical Pharmacology?

The topics of Pharmacokinetics, Pharmacology, Internal medicine, Anesthesia and Endocrinology are the focal point of discussions in The Journal of Clinical Pharmacology. The studies in Pharmacokinetics featured incorporate elements of Oral administration, Crossover study and Dosing. Many of the studies tackled connect Oral administration with a similar field of study like Metabolite.

As a part of it, discussions in Pharmacology involve topics like Bioavailability, Drug interaction, Drug, Volume of distribution and Tolerability. In addition to Internal medicine research, The Journal of Clinical Pharmacology aims to explore topics under Gastroenterology, Surgery and Cardiology. Issues in Anesthesia were discussed, taking into consideration concepts from other disciplines like Placebo, Adverse effect and Blood pressure, Heart rate.

The Blood pressure study tackled is a key component of adjacent topics in the area of Hemodynamics. The in-depth study on Renal function also explores topics in the intersecting field of Urology.

  • Pharmacokinetics (44.09%)
  • Pharmacology (42.38%)
  • Internal medicine (30.16%)

What are the most cited papers published in the journal?

  • Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. (1035 citations)
  • A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs (679 citations)
  • Pharmacokinetics and bioavailability of quercetin glycosides in humans. (478 citations)

Research areas of the most cited articles at The Journal of Clinical Pharmacology:

The most cited articles tackle a plethora of topics, such as Pharmacology, Pharmacokinetics, Internal medicine, Anesthesia and Oral administration. Issues in Pharmacology were discussed in the most cited papers, taking into consideration concepts from other disciplines like Placebo and Crossover study. Bioavailability and Dosing are some topics wherein Pharmacokinetics research discussed in the most cited publications has an impact.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Diabetes mellitus

The previous edition focused in particular on these issues:

The journal was organized to reinforce research efforts on Pharmacokinetics, Internal medicine, Dosing, Pharmacology and Gastroenterology. The journal deals with Pharmacokinetics in conjunction with Renal function and similar fields in Urology. The study on Internal medicine presented in The Journal of Clinical Pharmacology intersects with the topics under Oncology.

Topics in Dosing were tackled in line with various other fields like Anesthesia, Therapeutic drug monitoring, Regimen, Intensive care medicine and Pediatrics. It explores issues in Pharmacology which can be linked to other research areas like CYP3A4, CYP3A and In vivo. Studies on Gastroenterology discussed in it link to the field of Hepatic impairment.

The most cited articles from the last journal are:

  • PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol (8 citations)
  • Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias. (8 citations)
  • Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in The Journal of Clinical Pharmacology (based on the number of publications) are:

  • David J. Greenblatt (120 papers) published 3 papers at the last edition,
  • John C. Somberg (73 papers) absent at the last edition,
  • Hartmut Derendorf (58 papers) published 1 paper at the last edition,
  • John A. Wagner (47 papers) absent at the last edition,
  • Jerold S. Harmatz (45 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in The Journal of Clinical Pharmacology (based on the number of publications) are:

  • Pfizer (211 papers) published 6 papers at the last edition, 2 less than at the previous edition,
  • Novartis (172 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • Merck & Co. (161 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • Center for Drug Evaluation and Research (123 papers) published 11 papers at the last edition, 6 less than at the previous edition,
  • Bristol-Myers Squibb (120 papers) published 5 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.63% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.56% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.22% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.76% of all publications and 50.46% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Conclusion

In summary, The Journal of Clinical Pharmacology is a reputable journal that features comprehensive research studies with varying topics of focus such as Pharmacokinetics, Internal Medicine, and Pharmacology. Whether you are a prospective or practicing healthcare professional, expanding your knowledge through continuously reviewing research, such as those found in this journal, is essential. In particular, nurse practitioners may find this beneficial in developing expertise. If you are an aspiring nurse practitioner finding programs to enhance your studies, there are several options like the best nurse practitioner programs in delaware that can provide quality education and training. Overall, it is crucial to keep oneself updated with these research papers to foster growth and nourish scientific curiosity.

Top Publications

  • TMPRSS2: Potential Biomarker for COVID-19 Outcomes.

    Jonathan D. Strope;PharmD Cindy H. Chau;William D. Figg

    (2020)
    80 Citations
  • Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame.

    Neal L. Benowitz;Gideon St.Helen;Evangelia Liakoni

    (2021)
    37 Citations
  • Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters.

    Christine Xu;Ashique Rafique;Terra Potocky;Anne Paccaly

    (2021)
    33 Citations
  • Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias.

    Farzaneh Salem;Trevor N. Johnson;Arran B. J. Hodgkinson;Kayode Ogungbenro

    (2021)
    30 Citations
  • Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease—A Pilot Study

    Abhishek G. Sathe;Paul Tuite;Chi Chen;Yiwei Ma

    (2020)
    30 Citations
  • Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study.

    Darren Wilbraham;Paul H. Berg;Max Tsai;Emily Liffick

    (2020)
    27 Citations
  • Parametric Approaches in Population Pharmacokinetics

    Monia Guidi;Chantal Csajka;Thierry Buclin

    (2020)
    26 Citations
  • A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure

    (2021)
    26 Citations
  • Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy

    (2022)
    25 Citations
  • Model-Informed Dose Optimization in Pregnancy.

    Nupur Chaphekar;Steve Caritis;Raman Venkataramanan

    (2020)
    24 Citations

Related Online Degrees & Career Pathways

Pursuing a career in medicine in the USA often involves exploring diverse educational routes, including nursing pathways that offer both flexibility and accelerated options. For individuals without a nursing background, online ABSN programs for non nurses provide a streamlined entry into nursing, allowing students to move swiftly toward licensure and clinical practice.

For those already in nursing, programs like the 6-month RN to BSN program enable rapid advancement, enhancing qualifications and opening doors to leadership roles. Additionally, fast track nurse practitioner programs are ideal for nurses aiming to become advanced practice providers in the shortest possible time, balancing speed with comprehensive training.

Examining salary prospects is also crucial when considering career pathways. Psychiatric nurse practitioners, for instance, have varied salaries by state, reflecting demand and regional healthcare needs.

By combining accelerated educational programs with awareness of career outcomes, prospective medical professionals can strategically plan their education and career trajectory to maximize both time and reward.

Explore more about these opportunities through resources focused on online absn programs for non nurses, 6-month rn to bsn program, fast track nurse practitioner programs, and pmhnp salary insights.

Best Scientists Contributing to This Journal

Recently Published Articles